Study protocol of short versus long-term levetiracetam in brain tumors (LIBRA): a phase 3 randomized controlled trial

Abstract Background Seizures are common in patients with brain tumors, impacting daily life and healthcare burden. In contemporary neuro-oncology practice, levetiracetam is the most commonly prescribed anti-seizure medication (ASM). Although the practice is widely variable, levetiracetam is usually...

Descripción completa

Detalles Bibliográficos

Autores principales:	Archya Dasgupta, Shakthivel Mani, Abhishek Chatterjee, Sadhana Kannan, Aliasgar Moiyadi, Prakash Shetty, Vikas Singh, Nandini Menon, Arpita Sahu, Amitkumar Choudhary, Kajari Bhattacharya, Ameya Puranik, Indraja Dev, Sridhar Epari, Ayushi Sahay, Aekta Shah, Nazia Bano, Farnaz Shaikh, Tejpal Gupta
Formato:	Artigo
Lenguaje:	Inglês
Publicado:	BMC 2025-05-01
Colección:	BMC Cancer
Materias:	Seizures Levetiracetam Brain tumor Antiepileptics Glioma
Acceso en línea:	https://doi.org/10.1186/s12885-025-14305-7
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!